Free Trial

Emergent BioSolutions (EBS) News Today

→ Exposed: 3 CENT Crypto to Explode June 24th? (From True Market Insiders) (Ad)
Free EBS Stock Alerts
$6.19
-0.07 (-1.12%)
(As of 06/7/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends
June 8 at 6:40 AM | americanbankingnews.com
Emergent BioSolutions Inc. (NYSE:EBS) Director Sells $61,100.00 in Stock
June 8 at 1:26 AM | americanbankingnews.com
Traders Buy Large Volume of Put Options on Emergent BioSolutions (NYSE:EBS)
June 7 at 8:40 AM | insidertrades.com
Kathryn C. Zoon Sells 10,000 Shares of Emergent BioSolutions Inc. (NYSE:EBS) Stock
June 6 at 7:53 PM | marketbeat.com
Insider Selling: Emergent BioSolutions Inc. (NYSE:EBS) Director Sells 10,000 Shares of Stock
Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) Director Kathryn C. Zoon sold 10,000 shares of the stock in a transaction dated Tuesday, June 4th. The shares were sold at an average price of $6.11, for a total transaction of $61,100.00. Following the completion of the transaction, the director now owns 54,482 shares of the company's stock, valued at approximately $332,885.02. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
June 6 at 11:46 AM | marketbeat.com
Emergent BioSolutions Sees Unusually High Options Volume (NYSE:EBS)
Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) was the recipient of some unusual options trading on Thursday. Stock traders purchased 5,129 put options on the company. This is an increase of approximately 305% compared to the average volume of 1,265 put options.
June 6 at 9:02 AM | globenewswire.com
Emergent BioSolutions Continues Driving Progress Against the Opioid Epidemic & Recognizes National Naloxone Awareness Day
June 3, 2024 | marketbeat.com
Charles Schwab Investment Management Inc. Has $6.90 Million Holdings in Emergent BioSolutions Inc. (NYSE:EBS)
Charles Schwab Investment Management Inc. boosted its position in shares of Emergent BioSolutions Inc. (NYSE:EBS - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,873,984 shares of the biopharmaceutic
May 21, 2024 | investorplace.com
7 Stocks to Buy Immediately Following Strong Earnings
May 16, 2024 | investorplace.com
Vice Stock Vanguards: 3 Sin Stocks Delivering Heavenly Returns
May 10, 2024 | globenewswire.com
Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 23, 2024
May 2, 2024 | msn.com
Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
May 2, 2024 | msn.com
Emergent BioSolutions Reports Blockbuster Q1 Results, Raises Guidance: What's Going On With The Stock?
May 2, 2024 | bizjournals.com
Why this Gaithersburg biotech's stock is surging
May 2, 2024 | finance.yahoo.com
Q1 2024 Emergent BioSolutions Inc Earnings Call
May 2, 2024 | investorplace.com
Emergent BioSolutions Layoffs 2024: What to Know About the Latest EBS Job Cuts
May 2, 2024 | finance.yahoo.com
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
May 2, 2024 | investorplace.com
Why Is Emergent BioSolutions (EBS) Stock Up 57% Today?
May 2, 2024 | investorplace.com
EBS Stock Earnings: Emergent BioSolutions Beats EPS, Beats Revenue for Q1 2024
May 1, 2024 | bizjournals.com
Gaithersburg biotech to shutter Baltimore facility amid cost-cutting
May 1, 2024 | bizjournals.com
Emergent BioSolutions eliminating 300 jobs, shutting down multiple facilities
May 1, 2024 | finance.yahoo.com
Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
May 1, 2024 | finance.yahoo.com
Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
May 1, 2024 | globenewswire.com
Emergent BioSolutions Reports First Quarter 2024 Financial Results
May 1, 2024 | reuters.com
Emergent BioSolutions to lay off about 300 employees
May 1, 2024 | globenewswire.com
Emergent BioSolutions Announces Strategic Operational Changes to Stabilize Financial Position
May 1, 2024 | globenewswire.com
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
May 1, 2024 | markets.businessinsider.com
Emergent BioSolutions earnings: here's what Wall Street expects
April 30, 2024 | bizjournals.com
Emergent BioSolutions doling out big bonuses to retain top execs
April 30, 2024 | globenewswire.com
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
April 24, 2024 | msn.com
FDA approves Amneal's generic version of OTC Narcan
April 24, 2024 | marketbeat.com
Emergent BioSolutions (EBS) to Release Earnings on Wednesday
Emergent BioSolutions (NYSE:EBS) will be releasing earnings after the market closes on Wednesday, May 1, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=587152)
April 22, 2024 | globenewswire.com
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
April 17, 2024 | finance.yahoo.com
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses
April 14, 2024 | marketbeat.com
Short Interest in Emergent BioSolutions Inc. (NYSE:EBS) Expands By 16.1%
Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 5,700,000 shares, a growth of 16.1% from the March 15th total of 4,910,000 shares. Based on an average daily volume of 2,980,000 shares, the days-to-cover ratio is currently 1.9 days. Currently, 11.4% of the shares of the stock are short sold.
April 11, 2024 | marketbeat.com
Emergent BioSolutions' (EBS) Buy Rating Reiterated at Benchmark
Benchmark reiterated a "buy" rating and set a $5.00 price target on shares of Emergent BioSolutions in a report on Thursday.
April 5, 2024 | marketbeat.com
Assenagon Asset Management S.A. Acquires 651,480 Shares of Emergent BioSolutions Inc. (NYSE:EBS)
Assenagon Asset Management S.A. lifted its holdings in shares of Emergent BioSolutions Inc. (NYSE:EBS - Free Report) by 356.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 834,372 shares of the biopharmaceutical company's stock
April 1, 2024 | finance.yahoo.com
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
March 30, 2024 | marketbeat.com
Emergent BioSolutions Inc. (NYSE:EBS) Short Interest Down 20.8% in March
Emergent BioSolutions Inc. (NYSE:EBS - Get Free Report) saw a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 4,910,000 shares, a decrease of 20.8% from the February 29th total of 6,200,000 shares. Based on an average daily volume of 3,000,000 shares, the short-interest ratio is presently 1.6 days. Approximately 9.8% of the shares of the company are sold short.
March 28, 2024 | globenewswire.com
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
March 27, 2024 | bizjournals.com
Why this Maryland biotech furloughed 130 workers in Michigan
March 25, 2024 | globenewswire.com
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
March 12, 2024 | marketwatch.com
Emergent BioSolutions Shares Drop on S&P Downgrade
March 7, 2024 | realmoney.thestreet.com
Benchmark gets more bullish on Emergent BioSolutions, upgrades shares
March 7, 2024 | realmoney.thestreet.com
Emergent BioSolutions upgraded to Buy at Benchmark after 'upbeat' Q4 report
March 7, 2024 | finance.yahoo.com
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
March 7, 2024 | finance.yahoo.com
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript
March 7, 2024 | marketbeat.com
Emergent BioSolutions (NYSE:EBS) Lifted to Buy at Benchmark
Benchmark upgraded shares of Emergent BioSolutions from a "hold" rating to a "buy" rating and set a $5.00 target price on the stock in a report on Thursday.
March 7, 2024 | finance.yahoo.com
Q4 2023 Emergent BioSolutions Inc Earnings Call
March 7, 2024 | fool.com
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
March 6, 2024 | investorplace.com
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023
Get Emergent BioSolutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter.

Exposed: 3 CENT Crypto to Explode June 24th? (Ad)

Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…

Click For My #1 FREE Crypto for 2024

EBS Media Mentions By Week

EBS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

EBS
News Sentiment
▼
0.75

0.76
▲
Average
Medical
News Sentiment

EBS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

EBS Articles
This Week
▼
9

2
▲
EBS Articles
Average Week

Get Emergent BioSolutions News Delivered to You Automatically

Sign up to receive the latest news and ratings for EBS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:EBS) was last updated on 6/9/2024 by MarketBeat.com Staff

From Our Partners
Collapse of the Petrodollar
The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...
Colonial Metals | Sponsored
Top 5 Tech Stocks to Buy for 2024
The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...
Daily Market Alerts | Sponsored
Top 5 AI Stocks to Buy for 2024
The electric vehicle boom is accelerating – and fast.
Market Moving Trends | Sponsored
No Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free
Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...
Hedgeye | Sponsored
The Only Energy Play You Should Be Looking At
Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...
Wealthpin Pro | Sponsored
Biden Nomination CANCELED?
And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...
The Freeport Society | Sponsored
Exposed: 3 CENT Crypto to Explode June 24th?
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
RSVP: Charles Payne’s Cash Flow Workshop
Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...
Unstoppable Prosperity | Sponsored